ArticleRheumatology and therapy2026

Efficacy and Safety of Obexelimab to Treat IgG4-Related Disease: Protocol for a Global, Randomized, Placebo-Controlled Trial.

Emma L Culver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.